Labrys Biologics Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 13
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $825M
Latest Deal Amount

Labrys Biologics General Information

Description

Developer of preventative treatments for migraines. The company's lead candidate, LBR-101, is an anti-CGRP monoclonal antibody for the prevention og chronic and high frequency migraines.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Primary Office
  • 1810 Gateway Drive
  • Suite 230
  • San Mateo, CA 94404
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Labrys Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Jul-2014 $825M 0000 00000 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 03-Jan-2013 0000 0000 000.00 Completed Clinical Trials - Phase 2
To view Labrys Biologics’s complete valuation and funding history, request access »

Labrys Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view Labrys Biologics’s complete cap table history, request access »

Labrys Biologics Executive Team (9)

Name Title Board Seat Contact Info
Michael Chang Ph.D Vice President, Project Management
Marcelo Bigal Ph.D Chief Medical Officer
Michele Bronson Ph.D Vice President, Regulatory & Quality
You’re viewing 3 of 9 executive team members. Get the full list »

Labrys Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Labrys Biologics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaan Partners Venture Capital Minority 000 0000 000000 0
InterWest Health Partners Venture Capital Minority 000 0000 000000 0
Sofinnova Investments Venture Capital Minority 000 0000 000000 0
venBio Venture Capital Minority 000 0000 000000 0
To view Labrys Biologics’s complete investors history, request access »